NCT02212548View on ClinicalTrials.gov

Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2016

Conditions
Cancer of the Prostate
Interventions
DEVICE

PEG Hydrogel (SpaceOAR)

A single injection of PEG hydrogel (SpaceOAR) through the perineum under transrectal ultrasound guidance while under general anaesthetic.

Trial Locations (1)

2065

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards

All Listed Sponsors
lead

Royal North Shore Hospital

OTHER

NCT02212548 - Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose | Biotech Hunter | Biotech Hunter